Stress Disorder Treatment: Introduction
- Stress disorder is a mental health condition caused by either experiencing or witnessing a terrifying event. It can also occur after a traumatic event such as an accident, surgery, fracture, or burn injury.
- There are basically two types of stress disorders: acute stress disorder and posttraumatic stress disorder. Stress disorders are caused by witnessing a traumatic event and occurs within one month of the traumatic event. It may last for three to five days and can persists up to one month.
Read Report Overview – https://www.transparencymarketresearch.com/stress-disorder-treatment-market.html
- Common causes or traumatic events may include battlefield war, accidents, death, threat of death to oneself or others, threat of serious injury, and threat to physical integrity
- Common symptoms of stress disorders include reduced awareness about surroundings, sense of numbness, detached, recurrent memories of unwanted events, and severe emotional distress
- Common treatment for stress disorders includes cognitive behavioral therapy, anxiety medications, selective serotonin reuptake inhibitors (SSRIs), and antidepressants
Stress Disorder Treatment Market: Key Drivers
- High prevalence and rise in incidence of various stress disorders and chronic pain across the globe is estimated to drive the market during the forecast period
- According to U.S. Department of Veteran Affairs, between 6% and 33% of people experiencing traumatic event can develop stress disorders
- It is also estimated that around 50 million adults in the U.S. are affected with chronic pain, and the number is expected to rise due to growing cancer survival rates, obesity, diabetes, and ageing population
- Significant large number of accident cases, burn injuries, and surgical procedures are also key factors that are likely to propel the market during the forecast period
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79798
Posttraumatic Stress Disorder Segment to Dominate Global Market
- In terms of type, the global stress disorder treatment market can be classified into posttraumatic stress disorder, and acute stress disorder. The posttraumatic stress disorder segment is projected to dominate global market during the forecast period.
- Large number of accident incidences, postoperative pain, and growing number of patients with arthritis are major factors that are projected to drive the segment in the near future
Selective Serotonin Reuptake Inhibitors (SSRIs) Segment to Dominate the Market
- In terms of drugs, the global stress disorder treatment market can be classified into selective serotonin reuptake inhibitors (SSRIs) and antianxiety drugs. The selective serotonin reuptake inhibitors segment is projected to dominate global market during the forecast period.
- SSRIs are commonly prescribed medication for the treatment of depression, primarily due to fewer side-effects and higher effectiveness of the drugs in the treatment of stress disorders
Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=79798
Retail pharmacy Segment to Dominate the Market
- Based on distribution channel, the global stress disorder treatment market can be classified into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment is projected to dominate the global market during the forecast period.
- The retail pharmacy segment is projected to dominate the global market during the forecast period. Easy availability and accessibility of treatment medications at these stores, comparatively large number of stores, and low cost are key factors that are likely to contribute to the dominant share of the segment during the forecast period.
Asia Pacific Stress Disorder Treatment Market to Expand Rapidly
- In terms of region, the global stress disorder treatment market can be split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America is likely to dominate the global stress disorder treatment market during the forecast period. High prevalence and rise in chronic pain, increasing geriatric population, and increased cancer survival rates in the region are key factors that are expected to boost the market in North America during the forecast period.
- The stress disorder treatment market in Asia Pacific is anticipated to expand at a notable CAGR during the forecast period. Rapid expansion of the market in the region can be ascribed to a rise in the number of people suffering from neurological disorders and chronic pain in densely populated countries such as India and China, and improvement of healthcare infrastructure in the region.
- Significant expansion of the healthcare industry, easy access to healthcare facilities, and increase in investments in healthcare by leading players in Asia Pacific are expected to fuel the market in the region in the near future
Pre Book Stress Disorder Treatment Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=79798<ype=S
Key Players Operating in Global Stress Disorder Treatment Market
The global stress disorder treatment market is fragmented, with a large number of domestic players holding majority share in respective region. Prominent players operating in the global stress disorder treatment market include:
- Novartis AG
- Pfizer Inc.
- Mylan N.V.
- Teva Pharmaceutical Industries Limited
- Sun Pharmaceutical Industries Limited
- AstraZeneca plc
- Eli Lilly and Company
- GlaxoSmithKline plc
- Lundbeck A/S
- Johnson & Johnson
- Merck & Co., Inc.
- Sanofi S.A.
More Trending Reports by Transparency Market Research –
Electrophysiology Devices Market: https://www.prnewswire.com/news-releases/increasing-prevalence-of-atrial-fibrillation-to-underscore-electrophysiology-devices-market-growth-tmr-study-301106801.html
Medication-assisted Treatment Market: https://www.biospace.com/article/medication-assisted-treatment-market-competitive-analysis-and-key-developments/
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
